You Are Here:
This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Institution: Massachusetts General Hospital
Project Description: The purpose of this project was to develop a model of the liver allocation system to evaluate the costs, effectiveness and systemic implications of non-cadaveric organ replacement technologies (ORT). Using a previously developed and verified model of the current liver allocation system, the model was expanded and used to examine the following three aims:
Career Goals: Dr. Stahl is a physician in the Institute for Technology Assessment at the Massachusetts General Hospital. He received his M.D. from McGill Medical School, Montreal and served both his internship and residency in internal medicine at North Shore University Hospital, Cornell Medical School and Memorial Sloan-Kettering Cancer. He later earned his M.P.H. from the University of Pittsburgh School of Public Health.
Progress to Date: This grant has been completed. Dr. Stahl found organ replacement technologies production volume and durability remain cost-effectiveness in most cases. Regarding gaming and ethics, clinical urgency is only one of the many factors important to the public and the public may invoke different fairness principles depending on the relative clinical status of patients.
The information on this page is archived and provided for reference purposes only.